Semax (10ml)
$49.00
A synthetic heptapeptide derived from ACTH studied in laboratory research for its effects on neurotrophic signaling, neuroprotection, and cognitive function in preclinical models.
Buy 1
SAVE 0%
Buy 3
SAVE 20%
Buy 5
SAVE 33%
Buy 7+
SAVE 50%
Description
Semax is a synthetic heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro) originally derived from the adrenocorticotropic hormone (ACTH) fragment 4–7. Developed in Russia and studied extensively in preclinical and clinical research, Semax has been investigated for its effects on brain-derived neurotrophic factor (BDNF) expression and neuroprotective signaling in laboratory models of neurological injury and cognitive function.
Research has also explored its interactions with dopaminergic and serotonergic pathways, its anti-inflammatory properties in neural tissue models, and its comparative profile against other nootropic peptides. Semax is approved for medical use in Russia and Ukraine, providing a published clinical and preclinical foundation for laboratory investigation into its neurological mechanisms.
Supplied as a lyophilized Research Use Only (RUO) material, analytically verified for identity and purity with batch-specific Certificate of Analysis documentation.
